Cvs Health (CVS) Depreciation & Amortization (CF) (2009 - 2026)

Cvs Health's Depreciation & Amortization (CF) history runs 18 years deep, the most recent figure standing at $1.1 billion for Q1 2026.

• Quarterly Depreciation & Amortization (CF) fell 3.38% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.6 billion (down 1.0% YoY) and the FY2025 annual result came in at $4.6 billion, changed 0.2% from the prior year.
• Depreciation & Amortization (CF) was $1.1 billion for Q1 2026 at Cvs Health, down from $1.1 billion in the prior quarter.
• Across five years, Depreciation & Amortization (CF) topped out at $1.2 billion in Q2 2025 and bottomed at $1.0 billion in Q1 2023.
• A 5-year average of $1.1 billion and a median of $1.1 billion in 2023 frame the typical range for Depreciation & Amortization (CF).
• Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) declined 7.41% — and 2024, when it grew 13.69%.
• Cvs Health's Depreciation & Amortization (CF) stood at $1.0 billion in 2022, then increased by 8.72% to $1.1 billion in 2023, then climbed by 1.15% to $1.1 billion in 2024, then changed by 0.0% to $1.1 billion in 2025, then retreated by 2.79% to $1.1 billion in 2026.
• Business Quant data shows CVS's Depreciation & Amortization (CF) at $1.1 billion in Q1 2026, $1.1 billion in Q4 2025, and $1.1 billion in Q3 2025.